Other news

u-card-img-1
News
First patients successfully treated

An anti-diabetes therapy for treating severe infections in a rare disease

Congenital neutropenia

First patients suffering from a rare disease named Glycogen Storage Disease 1B have been successfully treated with an anti-diabetes therapy. This study is led by Maria Veiga-da-Cunha (senior research associate FRS-FNRS at UCLouvain) and Emile Van Schaftingen (WELBIO investigator at UCLouvain). The results have been published in Blood. For the first time in a WELBIO project, investigators make a successful step from basic research to actual patient treatment.

Learn more
u-card-img-1
News
Diabète de type 1

Un long ARN non codant régule l’inflammation des cellules beta du pancréas

Une étude publiée dans PNAS

Les équipes de Decio E. Eizirik et de Izortze Santin décrivent le mécanisme moléculaire par lequel  un long ARN non codant spécifique régule l’inflammation des cellules beta du pancréas et contribue à la pathogenèse du diabète de type 1.

Learn more

Share this page